Drug intelligence / Profile preview

cockroach allergen extract

Development stage: Unknown
Lead developer: Stallergenes Greer
Modality: Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration: Subcutaneous, Sublingual, Intratracheal, Intranasal

Overview

Cockroach allergen extract is a biological product derived from cockroaches, containing various allergenic proteins. It is utilized in research to induce allergic conditions, such as asthma in mouse models, facilitating the study of immune responses and potential therapeutic interventions. Clinically, it is employed for the diagnosis and immunotherapy of cockroach allergy, aiming to reduce sensitivity to the allergens.

Other names: CRE

Targets

IgE (Immunoglobulin E)TCR (T-cell receptor (allergen-reactive T cells))

Beyond the preview

Go deeper on cockroach allergen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on cockroach allergen extract.

Explore the full profile